Skip to Main Content

Author Details

James Buchanan
Health Economics Research Centre, University of Oxford
2007
47
16
PMIDPaper TitleJournal TitlePublished Year
37046271Retrospective file review shows limited genetic services fails most patients - an argument for the implementation of exome sequencing as a first-tier test in resource-constraint settings.Orphanet J Rare Dis2023
35194876Eliciting risk preferences that predict risky health behavior: A comparison of two approaches.Health Econ2022
35476801Factors that impact on women's decision-making around prenatal genomic tests: An international discrete choice survey.Prenat Diagn2022
35368231Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.Appl Health Econ Health Policy2022
35216902Defining a Core Data Set for the Economic Evaluation of Precision Oncology.Value Health2022
35089945Assessing women's preferences towards tests that may reveal uncertain results from prenatal genomic testing: Development of attributes for a discrete choice experiment, using a mixed-methods design.PLoS One2022
34337101Cost-Effectiveness of Amphotericin B Deoxycholate Versus Itraconazole for Induction Therapy of Talaromycosis in Human Immunodeficiency Virus-Infected Adults in Vietnam.Open Forum Infect Dis2021
33574068Availability and funding of clinical genomic sequencing globally.BMJ Glob Health2021
33682065Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom.Appl Health Econ Health Policy2021
33903739Toward the diagnosis of rare childhood genetic diseases: what do parents value most?Eur J Hum Genet2021
34409564What Aspects of Illness Influence Public Preferences for Healthcare Priority Setting? A Discrete Choice Experiment in the UK.Pharmacoeconomics2021
34758253100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.N Engl J Med2021
34460825Public preferences for delayed or immediate antibiotic prescriptions in UK primary care: A choice experiment.PLoS Med2021
34145384Correction to: Toward the diagnosis of rare childhood genetic diseases: what do parents value most?Eur J Hum Genet2021
31358947The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom.Genet Med2020
31741314A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic Disorders.Pharmacoeconomics2020
33066092Awareness of Appropriate Antibiotic Use in Primary Care for Influenza-Like Illness: Evidence of Improvement from UK Population-Based Surveys.Antibiotics (Basel)2020
32727604Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey.BMC Med2020
32389221Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling.Value Health2020
30284701Evaluating the Outcomes Associated with Genomic Sequencing: A Roadmap for Future Research.Pharmacoecon Open2019
31186546Do health professionals value genomic testing? A discrete choice experiment in inherited cardiovascular disease.Eur J Hum Genet2019
30835078Correction to: The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study.Pharmacoeconomics2019
30948524The challenge of antimicrobial resistance: What economics can contribute.Science2019
30941659A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine.Appl Health Econ Health Policy2019
30957659Duration of Treatment Effect Should Be Considered in the Design and Interpretation of Clinical Trials: Results of a Discrete Choice Experiment.Med Decis Making2019
30552651Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UK.Pharmacoecon Open2019
29785689The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study.Pharmacoeconomics2018
30224108Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions.Value Health2018
30224107Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions.Value Health2018
30224106Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions.Value Health2018
29446766Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.Genet Med2018
28762015Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis.Pharmacoeconomics2017
28320700Urgent improvements needed to diagnose and manage Lynch syndrome.BMJ2017
28882578Surgery versus surveillance in ulcerative colitis patients with endoscopically invisible low-grade dysplasia: a cost-effectiveness analysis.Gastrointest Endosc2017
27167075Patients' Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment.Patient2016
27503004Women's birth place preferences in the United Kingdom: a systematic review and narrative synthesis of the quantitative literature.BMC Pregnancy Childbirth2016
25680402Welfarism versus extra-welfarism: can the choice of economic evaluation approach impact on the adoption decisions recommended by economic evaluation studies?Pharmacoeconomics2015
26560056Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol.BMJ Open2015
25997802Management of patients with suspected infectious diarrhoea in hospitals in England.J Hosp Infect2015
25146932Can rapid integrated polymerase chain reaction-based diagnostics for gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic study.Health Technol Assess2014
24236483Issues surrounding the health economic evaluation of genomic technologies.Pharmacogenomics2013
21127355Clomifene citrate and intrauterine insemination as first-line treatments for unexplained infertility: are they cost-effective?Hum Reprod2011
21683300Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers.J Crohns Colitis2011
21206901Cost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illness.PLoS One2010
18305182Molecular testing for somatic cancer mutations: a survey of current and future testing in UK laboratories.J Clin Pathol2008
18505890Molecular testing for somatic mutations in common cancers: the views of UK oncologists.J Clin Pathol2008
18923927Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom.Genomic Med2007
  • 1 - 47 of 47

Recommended Authors

Koen Degeling
Cancer Health Services Research, The University of Melbourne
Career Start Year 2017
Number of shared co-authors 1
Hadley Stevens Smith
Center for Medical Ethics and Health Policy, Baylor College of Medicine
Career Start Year 2017
Number of shared co-authors 1
Nathaniel Hendrix
Harvard T.H. Chan School of Public Health
Career Start Year 2017
Number of shared co-authors 0
Thomas Butt
UCL Institute of Ophthalmology, University College London
Career Start Year 2013
Number of shared co-authors 1
Jeff Round
Institute of Health Economics, University of Alberta
Career Start Year 2010
Number of shared co-authors 2
Dalia Dawoud
Stanford University
Career Start Year 2010
Number of shared co-authors 1
Mike Paulden
School of Public Health, University of Alberta
Career Start Year 2009
Number of shared co-authors 1
Benjamin P Geisler
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 0
Nora B Henrikson
Kaiser Permanente Washington Health Research Institute
Career Start Year 2005
Number of shared co-authors 1
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 1
Nicholas Mitsakakis
Institute of Health Policy Management and Evaluation, University of Toronto
Career Start Year 2003
Number of shared co-authors 0
Fiona A Miller
Institute of Health Policy, University of Toronto
Career Start Year 2002
Number of shared co-authors 1
Emily Beth Devine
University of Washington
Career Start Year 1997
Number of shared co-authors 0
Andrew Walker
University of California San Diego
Career Start Year 1995
Number of shared co-authors 0
Mireille Goetghebeur
School of Public Health, Universite de Montreal 1
Career Start Year 1995
Number of shared co-authors 0
Ben van Hout
University of Sheffield
Career Start Year 1993
Number of shared co-authors 0
David O Meltzer
The University of Chicago
Career Start Year 1993
Number of shared co-authors 0
David L Veenstra
University of Washington
Career Start Year 1992
Number of shared co-authors 2
Jason N Doctor
University of Southern California
Career Start Year 1992
Number of shared co-authors 0
Jonathan J Deeks
Institute of Applied Health Research, University of Birmingham
Career Start Year 1991
Number of shared co-authors 1
Chris L Pashos
Data Sciences Institute, Takeda Pharmaceuticals International Inc.
Career Start Year 1990
Number of shared co-authors 0
Patrick M M Bossuyt
University of Amsterdam
Career Start Year 1989
Number of shared co-authors 0
Mark S Roberts
School of Public Health, University of Pittsburgh
Career Start Year 1988
Number of shared co-authors 0
Sean Tunis
Center for Evaluation of Value and Risk in Health, Tufts Medical Center
Career Start Year 1987
Number of shared co-authors 1
Joel Tsevat
Dell Medical School, University of Texas at Austin
Career Start Year 1987
Number of shared co-authors 0
John B Wong
Tufts University School of Medicine
Career Start Year 1986
Number of shared co-authors 0
Benjamin Djulbegovic
Medical University of South Carolina
Career Start Year 1985
Number of shared co-authors 0
Wendy J Ungar
The Hospital for Sick Children
Career Start Year 1984
Number of shared co-authors 1
Mark Helfand
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 0
Theodore G Ganiats
university of california san diego
Career Start Year 1983
Number of shared co-authors 0

Collaborators

Sarah Wordsworth
Health Economics Research Centre, University of Oxford
Co-authored papers 35
Jenny C Taylor
University of Oxford
Co-authored papers 9
Lyn S Chitty
UCL Institute of Child Health and Great Ormond Street NHS Foundation Trust
Co-authored papers 2
Christopher McCabe
Queens University Belfast
Co-authored papers 2
Kelly E Ormond
Stanford University School of Medicine
Co-authored papers 2
David J Burn
Population Health Sciences Institute, Newcastle University
Co-authored papers 2
Christopher C Butler
University of Oxford
Co-authored papers 2
John Taylor
Oxford University Hospitals NHS Foundation Trust, Churchill Hospital
Co-authored papers 2
Carme Camps
National Institute for Health Research Biomedical Research Centre
Co-authored papers 2
E V Davison
University of Newcastle upon Tyne.
Co-authored papers 2
Philip Twiss
Cambridge University Hospitals NHS Foundation Trust
Co-authored papers 1
Rutendo Mapeta
Cambridge University Hospitals NHS Foundation
Co-authored papers 1
Matthew Welland
Co-authored papers 1
Maureen Cleary
Great Ormond Street Hospital for Children NHS Trust
Co-authored papers 1
Stephanie Grunewald
Great Ormond Street Hospital for Children NHS Trust
Co-authored papers 1
Francesco Muntoni
UCL Great Ormond Street Institute of Child Health
Co-authored papers 1
Patricia A Deverka
Deverka Consulting LLC
Co-authored papers 1
Antonio Rueda Martin
Queen Mary University of London
Co-authored papers 1
Dragana Josifova
Guy's and St Thomas' Hospital
Co-authored papers 1
Douglass M Turnbull
Newcastle University
Co-authored papers 1
Valentina Cipriani
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 1
Christopher Boustred
Co-authored papers 1
Anna de Burca
Oxford University Hospitals NHS Foundation Trust
Co-authored papers 1
Charu Deshpande
Guy's Hospital
Co-authored papers 1
Bishoy Habib
Co-authored papers 1
Gr??inne S Gorman
Newcastle upon Tyne Hospitals NHS Foundation Trust
Co-authored papers 1
Dominic J McMullan
Birmingham Women's and Children's NHS Foundation Trust
Co-authored papers 1
No??mi B A Roy
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Co-authored papers 1
Sarju G Mehta
Cambridge University Hospitals NHS Foundation Trust
Co-authored papers 1
Tanya Lam
Co-authored papers 1
Release 1.2